Latham & Watkins represented Cadence in the transaction. Cadence Design Systems, Inc. (Nasdaq: CDNS) has entered into an agreement to acquire Future Facilities, a leading provider...
Cadence Design Systems’ Acquisition of Future Facilities
Unity’s Merger with ironSource
Morrison Foerster advised Unity Software Inc. on the deal, while Latham & Watkins advised ironSource. Unity Software Inc. (NYSE: U), the world’s leading platform for creating...
Sprague Resources’ Merger with Hartree Partners
Vinson & Elkins advised Hartree Partners, while Latham & Watkins represented the Conflicts Committee of Sprague in the transaction. Sprague Resources LP (NYSE: SRLP) (Sprague) has entered...
Blackstone Credit’s Acquisition of EIG’s 49% Interest in Elba Liquefaction Company
Milbank represented Blackstone Credit, while Latham & Watkins represented EIG in the transaction. Blackstone Credit has acquired EIG’s 49% ownership interest in Elba Liquefaction Company (“ELC”),...
TotalEnergies’ Acquisition of SunPower’s Commercial & Industrial Solutions Business
Latham & Watkins represented TotalEnergies in the transaction while Simpson Tacher advised SunPower in the transaction. TotalEnergies (NYSE:TTE) has signed a definitive agreement with SunPower Corp.’s...
GTCR’s Acquisition of Cisive
Latham & Watkins represented GTCR in the transaction, while Willkie Farr & Gallagher represented Cisive. GTCR, a leading private equity firm, has signed a definitive agreement to...
Virgin Orbit’s Merger With NextGen Acquisition Corp. II
Skadden, Arps, Slate, Meagher & Flom advised NextGen Acquisition Corp. II, while Latham & Watkins advised Virgin Orbit in the deal. Sullivan & Cromwell represented the...
Tremor International’s $1.5 Billion Initial Public Offering
Naschitz Brandes Amir and Latham & Watkins advised Tremor International on the deal. Tremor International Ltd. (Tremor) completed the pricing of its initial public offering of...
Science 37’s $1.05 Billion de-SPAC Transaction with LifeSci Acquisition II Corp.
Latham & Watkins LLP represented Science 37 in the transaction. Science 37, Inc. (Science 37), developer of the Decentralized Clinical Trial Operating SystemTM, and LifeSci Acquisition...